CTL (Cellular Technology Ltd.) has been pioneering the ELISPOT technology for immune monitoring. For over a decade, CTL’s mission has been “Elevating ELISPOT to an Exact Science”. Serving over 2,000 clients from academia and industry worldwide, CTL offers unparalleled expertise in immune monitoring.
AGENUS pursued the objective of targeting the immune system to fight disease, while building a broad and flexible immuno-oncology pipeline based on our deep expertise in the field of immunology.
Agenus’ comprehensive approach to cancer immunotherapy includes a diverse portfolio of antibodies including checkpoint inhibitors and other checkpoint modulators, vaccines and adjuvants.
Immudex provides a range of high quality products all based on the unique MHC Dextramer® technology.
GTCbio is a leading information center that provides quality forums, which facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
The mission of the Cure Cancer Now Foundation is to ultimately win the battle against cancer.
The Association for Cancer Immunotherapy (CIMT)
Cancer Immunology, Immunotherapy has the basic aim of keeping readers informed of the latest research results in the fields of oncology and immunology. CITIM Conference summary and Focus Research Reviews are published in CII.